Paradoxical nail psoriasis induced by the IL-17A inhibitor ixekizumab in palmoplantar pustulosis

Int J Dermatol. 2023 Jul;62(7):e370-e371. doi: 10.1111/ijd.16686. Epub 2023 Apr 14.

Authors

Raphaël André¹, Wolf-Henning Boehncke¹, Emmanuel Laffitte¹

Affiliation

¹ Division of Dermatology and Venereology, Geneva hospitals, University of Geneva, Geneva, Switzerland.

PMID: 37057631
DOI: 10.1111/ijd.16686

No abstract available

Publication types

Letter

MeSH terms

Acute Disease
Antibodies, Monoclonal, Humanized
Exanthema*
Humans
Interleukin-17
Psoriasis*

Substances

ixekizumab
Interleukin-17
Antibodies, Monoclonal, Humanized